(Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 29, 2023 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from ____________ to___________ Commission File Number 0-18655 EXPONENT, INC. (Exact name of registrant as specified in its charter) (State or other jurisdicti ...

Exponent Inc. (NASDAQ:EXPO) Q3 2023 Results Conference Call October 26, 2023 4:30 PM ET Company Participants Joni Konstantelos - Investor Relations Catherine Corrigan - President, CEO and Director Rich Schlenker - Executive VP, CFO and Corporate Secretary Conference Call Participants Tobey Sommer - Truist Josh Chan - UBS Andrew Nicholas - William Blair Operator Good day, and welcome to the Exponent Third Quarter Fiscal Year 2023 Earnings Conference Call. All participants will be in a listen-only mode. [Oper ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2023 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from ____________ to___________ Commission File Number 0-18655 EXPONENT, INC. (Exact name of registrant as specified in its charter) (State or other jurisdiction of ...

Exponent, Inc. (NASDAQ:EXPO) Q2 2023 Earnings Conference Call July 27, 2023 4:30 PM ET Company Participants Joni Konstantelos - Investor Relations Dr. Catherine Corrigan - President and CEO Rich Schlenker - Executive Vice President and CFO Conference Call Participants Josh Chan - UBS Tobey Sommer - Truist Operator Good day. And welcome to the Exponent’s Second Quarter Earnings Conference Call. All participants will be in listen-only mode. [Operator Instructions] After today’s presentation, there will be an ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2023 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from ____________ to___________ Commission File Number 0-18655 EXPONENT, INC. (Exact name of registrant as specified in its charter) DELAWARE 77-0218904 (State or ...

Financial Data and Key Metrics Changes - In Q1 2023, total revenues increased by 9.2% to $140.3 million, while net revenues rose to $128.7 million, reflecting a strong performance despite macroeconomic challenges [79] - Net income decreased by 1.6% to $29.1 million, maintaining earnings per diluted share at $0.56 [57] - EBITDA increased by 3.7% to $35.8 million, with an EBITDA margin of 27.8% [80] - Utilization dropped to 70.4% from 76.5% in the prior year, attributed to significant headcount growth [81] - The realized rate increase was approximately 6% for the first quarter compared to the same period a year ago [58] Business Line Data and Key Metrics Changes - The engineering and other scientific segment, which represents 83% of net revenues, increased by 11% year-over-year, driven by demand in transportation, utilities, consumer products, and life sciences [76] - The environmental and health segment accounted for 17% of net revenues but saw a 1% decrease compared to the prior year [54] Market Data and Key Metrics Changes - Increased demand for reactive services was noted, particularly in litigation-related activities and product safety across various industries [4] - Proactive engagements were primarily driven by regulatory issues and product design consulting in electronics and medical devices [51] Company Strategy and Development Direction - The company is focused on strategic hiring to meet the complex needs of clients, with a headcount growth of 12% year-over-year [6][13] - Exponent aims to capitalize on macro trends related to safety, health, and environmental concerns, positioning itself for future growth [75] - The company plans to continue investing in talent and capabilities to expand its client base and services [52] Management's Comments on Operating Environment and Future Outlook - Management expressed optimism about the ongoing demand for critical work despite market uncertainties, indicating that regulatory needs remain strong [23][35] - The full-year 2023 outlook remains unchanged, with expected revenue growth in the high-single to low-double digits and an EBITDA margin of 28% to 28.5% [16][85] - Management noted that the hiring environment has improved, with strong acceptance rates and retention contributing to headcount growth [100] Other Important Information - G&A expenses increased by 38.1% to $5.8 million, primarily due to increased marketing and recruiting activities [60] - The company expects a tax rate of approximately 28% for 2023, up from 27% in 2022 [89] Q&A Session Summary Question: What drove the stronger-than-expected headcount growth? - Management attributed the growth to strong acceptance rates and a robust employee value proposition, indicating a favorable hiring environment [100] Question: How did the reactive and proactive business lines perform? - The reactive side was stronger, particularly in litigation and recall-related work, while proactive engagements faced some delays due to client adjustments in response to market uncertainty [102][94] Question: Has there been any impact from recent layoffs in the tech sector? - Management noted that while some clients are resetting their teams, the demand for Exponent's services remains stable, and they have not observed a significant impact from the layoffs [109]

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K ☒ Annual Report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 for the fiscal year ended December 30, 2022. OR ☐ Transition report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 for the transition period from ________ to _________. Commission File Number 0-18655 EXPONENT, INC. (Exact name of registrant as specified in its charter) Delaware 77-0218904 (State or other jurisdiction ...

Exponent, Inc. (NASDAQ:EXPO) Q4 2022 Results Conference Call February 2, 2023 4:30 PM ET Company Participants Joni Konstantelos - IR Catherine Corrigan - President and Chief Executive Officer Rich Schlenker - Executive Vice President and Chief Financial Officer Conference Call Participants Jasper Bibb - Truist Andrew Nicholas - William Blair Operator Good day, and welcome to Exponent's Fourth Quarter and Fiscal Year 2022 Financial Results Conference Call. All participants will be in listen only mode [Operat ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2022 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from ____________ to___________ Commission File Number 0-18655 EXPONENT, INC. (Exact name of registrant as specified in its charter) | --- | --- | |----------- ...

Exponent, Inc. (NASDAQ:EXPO) Q3 2022 Earnings Conference Call October 27, 2022 4:30 PM ET Company Participants Joni Konstantelos - Investor Relations Catherine Ford Corrigan - President and Chief Executive Officer Richard Schlenker - Executive Vice President, Chief Financial Officer & Corporate Secretary Conference Call Participants Operator Good day and welcome to the Exponent, Incoporated Third Quarter of Fiscal Year 2022 Financial Results Conference Call. Today's conference is being recorded. And now at ...